HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow.

AbstractBACKGROUND:
Coronary slow flow (CSF) is a special coronary microvascular disorder. The pathogenesis and effective therapeutics of CSF remain unclear. This study aimed to evaluate the global and regional functions of the left ventricle (LV) and investigate the efficacy of nicorandil in patients with CSF.
PATIENTS AND METHODS:
Thirty-six patients with CSF in the left anterior descending (LAD) branch and 20 patients with normal coronary arteries were included. Global and regional functions of the LV supplied by LAD were measured using conventional Doppler echocardiography and two-dimensional speckle tracking echocardiography, respectively, within 24 h after coronary angiography. Concentrations of plasma nitric oxide (NO) and endothelin-1 (ET-1) were detected using colorimetry and radioimmunoassay, respectively. The function of the LV and the levels of NO and ET-1 were also investigated before and 90 days after treatment with 15 mg/day of nicorandil.
RESULTS:
Compared with the control group, the early diastolic peak velocity (E), E/A ratio, and plasma NO levels were lower, whereas the late diastolic peak flow velocity (A) and plasma ET-1 levels were significantly higher in the CSF group (P<0.05). The longitudinal strain rate peak of the LV was reduced significantly in CSF patients (P<0.001). After treatment, 75% (27/36) of CSF patients were free of chest pain. The values of E peak, E/A ratio, longitudinal strain rate peak, and plasma NO level were increased (P<0.001), whereas the ET-1 level was decreased in CSF patients (P<0.001).
CONCLUSION:
Nicorandil may improve chest pain symptoms and the impaired function of the LV, possibly by increasing plasma NO and reducing ET-1 in CSF.
AuthorsZuoyuan Chen, Xiuhua Chen, Shan Li, Xuezhen Huo, Xiuxiu Fu, Xiaonan Dong
JournalCoronary artery disease (Coron Artery Dis) Vol. 26 Issue 2 Pg. 114-20 (Mar 2015) ISSN: 1473-5830 [Electronic] England
PMID25325437 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Arrhythmia Agents
  • Endothelin-1
  • Nicorandil
  • Nitric Oxide
Topics
  • Aged
  • Anti-Arrhythmia Agents (therapeutic use)
  • Colorimetry
  • Coronary Angiography
  • Echocardiography, Doppler
  • Endothelin-1 (blood)
  • Female
  • Heart (physiology)
  • Humans
  • Male
  • Middle Aged
  • Nicorandil (therapeutic use)
  • Nitric Oxide (blood)
  • No-Reflow Phenomenon (drug therapy, physiopathology)
  • Radioimmunoassay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: